07/20/2016 - 1:26pm

"Working together with NCPA staff, the Innovation Center will help better position independent community pharmacies to be part of and benefit from broader health care changes," suggested Doug Hoey, NCPA CEO.

07/20/2016 - 10:57am

The pilot program would allow the Department of Defense to access lower pricing for prescriptions dispensed at community pharmacies.

07/19/2016 - 3:48pm
The expanded label also comes with two new dosage strengths, which the companies said will be available in September. 
07/19/2016 - 3:28pm
The new indication makes the drug available for treatment-naïve adults with type 2 diabetes as an adjunct to diet and exercise as a way of improving glycemic control. 
07/19/2016 - 3:16pm

The drug is a new formulation of lorcaserin that can offer patients once-daily dosing and could help maintain weight loss. 

07/18/2016 - 3:28pm

Cefaly I has a tremendous success record. In clinical trials 81% of compliant patients showed a significant reduction in migraine attacks and up to a 75% reduction in consumption of migraine medications.

07/18/2016 - 11:49am

Industry organizations have responded to the Food and Drug Administration’s issuing of a document with details on the reauthorization of the Prescription Drug User Fee agreement. 

07/18/2016 - 10:12am

The Food and Drug Administration has approved a bew indication for Janssen Therapeutics’ Prezista (darunavir), the company announced Monday.

07/13/2016 - 11:53am
Reuters is reporting that the FDA’s Arthritis Advisory Board has unanimously recommended Amgen’s biosimilar of AbbVie’s Humira, ABP 501. The panel said that the drug was similar in safety and effectiveness to Humira for rheumatoid arthritis and plaque psoriasis, and it recommended that the biosimilar should also be approved for Crohn’s disease in adults and ulcerative colitis. (Reuters)